| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/24/2013 | CN101970474B Cyclic, cystein-free protein |
| 04/24/2013 | CN101848720B 糖尿病治疗剂 Therapeutic agents for diabetes |
| 04/24/2013 | CN101816782B Composite enzyme apophlegmatisant |
| 04/24/2013 | CN101798337B Mutant of endotoxin neutralizing peptide and application thereof |
| 04/24/2013 | CN101703764B Medicament for treating degenerative osteopathy and preparation method thereof |
| 04/24/2013 | CN101684159B Protein derivatives of human granzyme B, and use thereof in targeted therapy on adenocarcinoma |
| 04/24/2013 | CN101643789B RNA interference mediating small RNA molecules |
| 04/24/2013 | CN101597321B LHRH antagonist with long-acting low-histamine release side effect |
| 04/24/2013 | CN101588809B Fermented milk for improving and/or treating skin and method for producing the same |
| 04/24/2013 | CN101555284B Truncated-type human ciliary nerve nutrition factor active segment and fusion protein thereof |
| 04/24/2013 | CN101531703B Beta lamellar blocking peptide for preventing and/or curing Alzheimer's disease |
| 04/24/2013 | CN101516374B Histone deacetylase inhibitors with combined activity on class-i and class-iib histone deacetylases in combination with proteasome inhibitors |
| 04/24/2013 | CN101300346B Novel biological substance nesfatin and its related substances and uses thereof |
| 04/24/2013 | CN101267831B Compositions and methods for promoting hemostasis and other physiological activities |
| 04/24/2013 | CN101250531B Nucleotide sequence, expression vector containing the same, zooblast inverted from said vector and method for producing human FSH using the zooblast |
| 04/24/2013 | CN101238145B Use of modified pore-forming proteins in preparing medicine for treating or preventing benign prostatic hyperplasia |
| 04/24/2013 | CN101232896B Method of treating or preventing tissue deterioration, injury or damage due to congestive heart failure |
| 04/24/2013 | CN101124331B Site-directed modification of FVIII |
| 04/24/2013 | CN101072551B Sustained release formulation comprising bisphosphonate |
| 04/23/2013 | US8426592 Histone deacetylases, and uses related thereto |
| 04/23/2013 | US8426575 N-linked glycosylation alteration in E1 glycoprotein of classical swine fever virus and novel classical swine fever virus vaccine |
| 04/23/2013 | US8426573 Nucleic acids encoding TNFγ |
| 04/23/2013 | US8426571 Nucleic acids and corresponding proteins entitled 202P5A5 useful in treatment and detection of cancer |
| 04/23/2013 | US8426562 Methods and compositions for modulating tumor cell activity |
| 04/23/2013 | US8426560 Microwave-assisted peptide synthesis |
| 04/23/2013 | US8426557 IGF-1R binding polypeptides and their use |
| 04/23/2013 | US8426391 Treating vitamin D insufficiency and deficiency with 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3 |
| 04/23/2013 | US8426368 Method of ameliorating oxidative stress and supplementing the diet |
| 04/23/2013 | US8426367 Peptides specific for human blood outgrowth endothelial cells |
| 04/23/2013 | US8426366 Disease treatment via antimicrobial peptides or their inhibitors |
| 04/23/2013 | US8426365 Method of treating or preventing tissue deterioration, injury or damage due to congestive heart failure |
| 04/23/2013 | US8426364 Method of preventing progression of hypertension-induced heart failure with PKC peptides |
| 04/23/2013 | US8426363 Method for reducing a level of LDL-cholesterol by an antibody that specifically binds to PCSK9 |
| 04/23/2013 | US8426362 Compositions comprising SIA for the treatment of diabetes |
| 04/23/2013 | US8426360 Carbocyclic oxime hepatitis C virus serine protease inhibitors |
| 04/23/2013 | US8426359 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
| 04/23/2013 | US8426358 Methods for treating atherosclerosis |
| 04/23/2013 | US8426357 Multimeric conjugate |
| 04/23/2013 | US8426355 Methods of treating muscular wasting diseases using NF-κB activation inhibitors |
| 04/23/2013 | US8426205 Method for selective electrofusion of at least two fusion partners having cell-like membranes |
| 04/23/2013 | US8426198 In vitro differentiated cell and human embryonic stem cell population |
| 04/23/2013 | US8426184 Cellulase activity; used to make bioethanol, in food and textile treatment, in waste treatment; breaks down lignocellulose |
| 04/23/2013 | US8426179 Synthetic peptide and peptide conjugates and related tissue coupling methods via transglutaminase enzyme |
| 04/23/2013 | US8426167 Methods for producing fusion polypeptides or enhancing expression of fusion polypeptides |
| 04/23/2013 | US8426166 Long-acting polypeptides and methods of producing same |
| 04/23/2013 | US8426145 Diagnostic method for celiac sprue |
| 04/23/2013 | US8425908 Treatment with anti-ErbB2 antibodies |
| 04/23/2013 | US8425901 Alpha 1-3 N-galactosyltransferase with altered donor specificities |
| 04/23/2013 | US8425900 Method of delivering a protein into a cell |
| 04/23/2013 | US8425896 Treatment of tumors with recombinant interferon alpha |
| 04/23/2013 | US8425895 polynucleotide encoding a protein that is non-naturally occurring and has enhanced anti-viral and anti-proliferative activity in comparison to human interferon alpha 2b (HuIFN- alpha 2b); treating cancer responsive to interferon alpha therapy |
| 04/23/2013 | US8425876 Gene encoding a multidrug resistance human P-glycoprotein homologue on chromosome 7P15-21 and uses thereof |
| 04/23/2013 | CA2658326C Neuregulins for prevention and treatment of damage from acute assault on vascular and neuronal tissue |
| 04/23/2013 | CA2588911C Therapeutic nutrient compositions or combinations and methods of their use |
| 04/23/2013 | CA2544972C Use of interleukin-22 as a biomarker of resistance to hiv infections in humans and biological applications thereof |
| 04/23/2013 | CA2530667C Protein crystal comprising the processivity clamp factor of dna polymerase and a ligand, and its uses |
| 04/23/2013 | CA2516331C Combination therapy using glycosaminoglycans and therapeutic agents for the treatment of respiratory disorders |
| 04/23/2013 | CA2494764C Treatment of melanoma by reduction in clusterin levels |
| 04/23/2013 | CA2473212C Pharmaceutical composition which improves in vivo gene transfer |
| 04/23/2013 | CA2471355C Substituted diketopiperazines as oxytocin antagonists |
| 04/23/2013 | CA2458394C Lipophilic drug compositions |
| 04/23/2013 | CA2422890C Method of predicting the clinical response to chemotherapeutic treatment with alkylating agents |
| 04/23/2013 | CA2416761C Method for screening peptides for use in immunotherapy |
| 04/23/2013 | CA2410563C Methods for preventing strokes by inducing tolerance to e-selectin |
| 04/23/2013 | CA2410153C A novel bacillus thuringiensis strain, crystal gene and crystal protein and uses thereof |
| 04/23/2013 | CA2400838C Novel method for down-regulation of amyloid |
| 04/23/2013 | CA2377517C Amphiphilic drug-oligomer conjugates with hydrolyzable lipophile components and methods for making and using the same |
| 04/23/2013 | CA2377107C Delivery of trefoil peptides |
| 04/23/2013 | CA2346375C Method for the treatment of chemonucleolysis |
| 04/23/2013 | CA2308571C Single-chain bifunctional glycoprotein hormones |
| 04/21/2013 | CA2851104A1 Methods for treating hcv |
| 04/21/2013 | CA2811250A1 Methods for treating hcv |
| 04/21/2013 | CA2811203A1 Methods for treating hcv |
| 04/18/2013 | WO2013056255A1 Methods and compositions for inhibiting tumor cell proliferation |
| 04/18/2013 | WO2013056248A2 Treatment of breast cancer with companion diagnostic |
| 04/18/2013 | WO2013056221A1 Compositions and methods for modulating thrombin generation |
| 04/18/2013 | WO2013056197A1 Degradation resistant hsp70 formulations and uses thereof |
| 04/18/2013 | WO2013056147A1 Topical formulations of chemerin c15 peptides for the treatment of dermatological conditions |
| 04/18/2013 | WO2013056132A2 Porous nanoparticle-supported lipid bilayers (protocells) for targeted delivery including transdermal delivery of cargo and methods thereof |
| 04/18/2013 | WO2013056122A1 Engineered outer domain (eod) of hv gp120 and mutants thereof |
| 04/18/2013 | WO2013056096A1 Polypeptide-opioid conjugates and uses thereof |
| 04/18/2013 | WO2013056054A2 Peptide inhibitors of bace1 |
| 04/18/2013 | WO2013056008A1 Zymogen activators |
| 04/18/2013 | WO2013055929A1 Non-n-glycosylated recombinant human annexin a2 |
| 04/18/2013 | WO2013055922A1 Use of semaphorin-4d binding molecules for modulation of blood brain barrier permeability |
| 04/18/2013 | WO2013055888A2 Recombinant human naglu protein and uses thereof |
| 04/18/2013 | WO2013055811A1 Ex vivo methods of predicting responsiveness of a subject to interferon therapy |
| 04/18/2013 | WO2013055745A2 Cd40l-specific tn3-derived scaffolds and methods of use thereof |
| 04/18/2013 | WO2013055734A1 Treatment of degenerative joint disease |
| 04/18/2013 | WO2013055699A1 Novel asparaginase and methods for treating diseases associated with asparagine dependence |
| 04/18/2013 | WO2013055438A1 Partially hydrolyzed casein-whey nutritional compositions for reducing the onset of allergies |
| 04/18/2013 | WO2013055251A1 Oral pharmaceutical composition for the treatment of inflammatory gastrointestinal diseases |
| 04/18/2013 | WO2013055073A2 Ophthalmic composition containing cyclosporine and method for preparing same |
| 04/18/2013 | WO2013055058A2 Antibody-binding peptide-ferritin fusion protein and uses thereof |
| 04/18/2013 | WO2013054534A1 DRUGS FOR DISEASES ASSOCIATED WITH AMYLOID β, AND SCREENING THEREFOR |
| 04/18/2013 | WO2013054329A1 Toll-like receptor 4 (tlr-4) agonist peptides for modulating tlr-4 mediated immune response |
| 04/18/2013 | WO2013053954A1 Method of diagnosis, prognostic or treatment of neurodegenerative diseases |
| 04/18/2013 | WO2013053775A1 Combination medicament comprising il-12 and an agent for blockade of t-cell inhibitory molecules for tumour therapy |
| 04/18/2013 | WO2013053772A1 Antimicrobial peptides for treatment of infectious diseases |
| 04/18/2013 | WO2013053201A1 Compositions and methods for treating heart failure |